Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes

Standard

Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes. / Ismail, Sadek; Gherardi, Marie-Julie; Froese, Alexander; Zanoun, Madjid; Gigoux, Véronique; Clerc, Pascal; Gaits-Iacovoni, Frederique; Steyaert, Jan; Nikolaev, Viacheslav O; Fourmy, Daniel.

In: BIOCHEM PHARMACOL, Vol. 120, 15.11.2016, p. 33-45.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Ismail, S, Gherardi, M-J, Froese, A, Zanoun, M, Gigoux, V, Clerc, P, Gaits-Iacovoni, F, Steyaert, J, Nikolaev, VO & Fourmy, D 2016, 'Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes', BIOCHEM PHARMACOL, vol. 120, pp. 33-45. https://doi.org/10.1016/j.bcp.2016.09.009

APA

Ismail, S., Gherardi, M-J., Froese, A., Zanoun, M., Gigoux, V., Clerc, P., Gaits-Iacovoni, F., Steyaert, J., Nikolaev, V. O., & Fourmy, D. (2016). Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes. BIOCHEM PHARMACOL, 120, 33-45. https://doi.org/10.1016/j.bcp.2016.09.009

Vancouver

Bibtex

@article{ae8cda48d0db42448c76d150858afcbf,
title = "Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes",
abstract = "Until very recently, G-protein dependent signal of GPCRs was thought to originate exclusively from the plasma membrane and internalized GPCRs were considered silent. Here, we demonstrated that, once internalized and located in the membrane of early endosomes, glucose-dependent Insulinotropic receptor (GIPR) continues to trigger production of cAMP and PKA activation. Direct evidence is based on identification of the active form of Gαs in early endosomes containing GIPR using a genetically encoded GFP tagged nanobody, and on detection of a distinct FRET signal accounting for cAMP production at the surface of endosomes containing GIP, compared to endosomes without GIP. Furthermore, decrease of the sustained phase of cAMP production and PKA activation kinetics as well as reversibility of cAMP production and PKA activity following GIP washout in cells treated with a pharmacological inhibitor of GIPR internalization, and continuous increase of cAMP level over time in the presence of dominant-negative Rab7, which causes accumulation of early endosomes in cells, were noticed. Hence the GIPR joins the few GPCRs which signal through G-proteins both at plasma membrane and on endosomes.",
author = "Sadek Ismail and Marie-Julie Gherardi and Alexander Froese and Madjid Zanoun and V{\'e}ronique Gigoux and Pascal Clerc and Frederique Gaits-Iacovoni and Jan Steyaert and Nikolaev, {Viacheslav O} and Daniel Fourmy",
note = "Copyright {\textcopyright} 2016 Elsevier Inc. All rights reserved.",
year = "2016",
month = nov,
day = "15",
doi = "10.1016/j.bcp.2016.09.009",
language = "English",
volume = "120",
pages = "33--45",
journal = "BIOCHEM PHARMACOL",
issn = "0006-2952",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes

AU - Ismail, Sadek

AU - Gherardi, Marie-Julie

AU - Froese, Alexander

AU - Zanoun, Madjid

AU - Gigoux, Véronique

AU - Clerc, Pascal

AU - Gaits-Iacovoni, Frederique

AU - Steyaert, Jan

AU - Nikolaev, Viacheslav O

AU - Fourmy, Daniel

N1 - Copyright © 2016 Elsevier Inc. All rights reserved.

PY - 2016/11/15

Y1 - 2016/11/15

N2 - Until very recently, G-protein dependent signal of GPCRs was thought to originate exclusively from the plasma membrane and internalized GPCRs were considered silent. Here, we demonstrated that, once internalized and located in the membrane of early endosomes, glucose-dependent Insulinotropic receptor (GIPR) continues to trigger production of cAMP and PKA activation. Direct evidence is based on identification of the active form of Gαs in early endosomes containing GIPR using a genetically encoded GFP tagged nanobody, and on detection of a distinct FRET signal accounting for cAMP production at the surface of endosomes containing GIP, compared to endosomes without GIP. Furthermore, decrease of the sustained phase of cAMP production and PKA activation kinetics as well as reversibility of cAMP production and PKA activity following GIP washout in cells treated with a pharmacological inhibitor of GIPR internalization, and continuous increase of cAMP level over time in the presence of dominant-negative Rab7, which causes accumulation of early endosomes in cells, were noticed. Hence the GIPR joins the few GPCRs which signal through G-proteins both at plasma membrane and on endosomes.

AB - Until very recently, G-protein dependent signal of GPCRs was thought to originate exclusively from the plasma membrane and internalized GPCRs were considered silent. Here, we demonstrated that, once internalized and located in the membrane of early endosomes, glucose-dependent Insulinotropic receptor (GIPR) continues to trigger production of cAMP and PKA activation. Direct evidence is based on identification of the active form of Gαs in early endosomes containing GIPR using a genetically encoded GFP tagged nanobody, and on detection of a distinct FRET signal accounting for cAMP production at the surface of endosomes containing GIP, compared to endosomes without GIP. Furthermore, decrease of the sustained phase of cAMP production and PKA activation kinetics as well as reversibility of cAMP production and PKA activity following GIP washout in cells treated with a pharmacological inhibitor of GIPR internalization, and continuous increase of cAMP level over time in the presence of dominant-negative Rab7, which causes accumulation of early endosomes in cells, were noticed. Hence the GIPR joins the few GPCRs which signal through G-proteins both at plasma membrane and on endosomes.

U2 - 10.1016/j.bcp.2016.09.009

DO - 10.1016/j.bcp.2016.09.009

M3 - SCORING: Journal article

C2 - 27641811

VL - 120

SP - 33

EP - 45

JO - BIOCHEM PHARMACOL

JF - BIOCHEM PHARMACOL

SN - 0006-2952

ER -